|
Delayed
Nasdaq Stockholm
04:57:39 2026-09-11 am EDT
|
5-day change | 1st Jan Change | ||
| 1.850 SEK | -2.53% |
|
+8.19% | -6.09% |
| Sep. 03 | Irlab CEO Kristina Torfgaard to step down in 2027 | FW |
| Sep. 03 | Irlab CEO Kristina Torfgaard wants to step down | FW |
| Market Cap | 282M 29.21M 25.12M 23.7M 21.59M 40.36M 2.79B 40.73M 109M 1.42B 110M 107M 4.5B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 282M 29.21M 25.12M 23.7M 21.59M 40.36M 2.79B 40.73M 109M 1.42B 110M 107M 4.5B | EV / Sales 2026 * |
2.79x | EV / Sales 2027 * | 1.97x |
| Free-Float |
83.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| IRLAB A | Delayed | |
Deutsche Boerse AG
| 6IRA | Delayed |
Last Transcript : IRLAB Therapeutics AB
| 1 day | -2.53% | ||
| 1 week | +8.19% | ||
| Current month | +3.24% | ||
| 1 month | +20.92% | ||
| 3 months | +45.90% | ||
| 6 months | +16.06% | ||
| Current year | -6.09% |
| 1 week | 1.69 |  | 1.96 |
| 1 month | 1.52 | | 1.96 |
| Current year | 1.17 | | 2.14 |
| 1 year | 1.17 | | 3.08 |
| 3 years | 1.17 | | 20.2 |
| 5 years | 1.17 | | 53 |
| 10 years | 1.17 | | 110 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2024-07-31 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 2012-12-31 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 2015-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 2015-12-31 |
| Chairman | 73 | 2020-05-06 | |
| Chairman | 68 | 2023-02-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/1/26 | Buy | Chairman | 31,000 | 38.8588% | ||
| 7/1/26 | Buy | Chief Technology Officer | 4,016,742 | - | ||
| 7/1/26 | Buy | Chief Executive Officer | 183,858 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.53% | +8.19% | -36.97% | -76.28% | 29.21M | |
| -0.11% | -3.16% | +48.82% | +91.49% | 1,001B | |
| -0.27% | -4.34% | +51.52% | +65.89% | 642B | |
| +1.63% | -2.00% | +20.49% | +71.12% | 451B | |
| +0.32% | -2.75% | +29.36% | +36.75% | 340B | |
| +0.77% | -12.52% | +11.38% | +28.37% | 263B | |
| +0.61% | -1.35% | -0.94% | +12.78% | 247B | |
| -2.25% | -13.88% | +37.33% | +47.43% | 207B | |
| -2.30% | -6.29% | -19.02% | -59.04% | 197B | |
| -0.58% | -4.24% | +25.65% | +90.54% | 180B | |
| Average | -0.38% | -3.95% | +16.76% | +30.90% | 352.64B | |
| Weighted average by Cap. | +0.11% | -4.65% | +31.90% | +57.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 101M 10.47M 9.01M 8.5M 7.74M 14.47M 1B 14.6M 38.95M 508M 39.32M 38.46M 1.61B | 143M 14.82M 12.74M 12.02M 10.95M 20.48M 1.42B 20.66M 55.11M 719M 55.65M 54.43M 2.28B |
| Net income | -36.1M -3.74M -3.21M -3.03M -2.76M -5.16M -357M -5.21M -13.89M -181M -14.03M -13.72M -575M | 34.6M 3.58M 3.08M 2.91M 2.65M 4.95M 342M 4.99M 13.32M 174M 13.44M 13.15M 551M |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
Nov. 10
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | SEK 1.850 | -2.53% | 477,596 |
| 26-09-10 | SEK 1.898 | +0.96% | 928,473 |
| 26-09-09 | SEK 1.880 | +5.50% | 1,396,457 |
| 26-09-08 | SEK 1.782 | +3.24% | 701,646 |
| 26-09-07 | SEK 1.726 | +0.94% | 409,799 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IRLAB A Stock
Select your edition
All financial news and data tailored to specific country editions
